Surgical options in heart failure

Westaby, Stephen; Narula, Jagat

doi:10.1016/j.suc.2004.01.008

Cited by 2 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nontransplant treatment options short of LVAD include the following: 1) revascularization in severe ischemic LV dysfunction [9,10]; 2) mitral valve repair for functional mitral regurgitation [11]; 3) LV remodeling procedures [12] (preliminary reports are encouraging and have led to the multicenter STICH [Surgical Treatment of Ischemic Heart Failure] trial); and 4) experimental approaches including dynamic cardiomyoplasty, the Acorn (Acorn Cardiovascular, St. Paul, MN), and the Myosplint procedures.…”

Section: Overview Of Current Treatment Options Medical Managementmentioning

confidence: 99%

Left ventricular assist devices for the treatment of congestive heart failure

Haddad

Lam

Hendry

et al. 2005

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

The mainstay of heart failure therapy is aggressive medical management with consideration of resynchronization therapy and automatic implantable cardioverter-defibrillator. This is best done with the support of a multidisciplinary team. Transplantation, when possible, remains the therapy of choice for patients who are refractory to medical therapy. Other options short of left ventricular assist device (LVAD) that should be considered include revascularization, mitral valve repair, and left ventricular remodeling procedures. LVAD therapy as a bridge to transplantation should be considered in patients with heart failure who are clinically deteriorating while on the transplant waiting list. This should be initiated prior to the onset of irreversible end-organ damage. In nontransplant candidates, an LVAD can be considered as an alternative to transplantation (destination therapy). However, cost and the availability of expertise continue to limit this therapy to quaternary care and research institutions.

show abstract

Section: Overview Of Current Treatment Options Medical Managementmentioning

confidence: 99%

Left ventricular assist devices for the treatment of congestive heart failure

Haddad

Lam

Hendry

et al. 2005

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

show abstract

“…Although cardiac transplantation remains the sole radical treatment for end stage CHF, shortage of donors along with immunosupression complications pose severe limitations to this approach. Techniques involving reshaping of the dilated left ventricle have been described and involve either endoventricular circular patch plasty (Dor procedure) or passive constraint and shape change [4,5]. Left ventricular assist devices serving mainly as a bridge to cardiac transplantation cannot be considered a long-term solution.…”

Section: Introductionmentioning

confidence: 99%

Adult bone marrow-derived stem cells and the injured heart: just the beginning?

Dimarakis

Habib

Gordon

2005

European Journal of Cardio-Thoracic Surgery

View full text Add to dashboard Cite

Coronary artery disease leading to ischaemia of the human myocardium is one of the chief causes of morbidity and mortality in the western world. Cellular transplantation has recently been proposed as a novel alternative treatment modality. Adult bone marrow-derived autologous cells are one of the key cell types under investigation in both the experimental and clinical setting. A range of theories has been proposed with regard to the observed myocardial function improvement in both human and animal studies. A concerted interest in scientific questions needs to be constructed on the regenerative information made available throughout the last years. It is only now that we begin to fully understand this fast growing body of research and how it may have wide ranging implications for the treatment of ischemic heart disease.

show abstract

Surgical options in heart failure

Cited by 2 publications

References 1 publication

Left ventricular assist devices for the treatment of congestive heart failure

Left ventricular assist devices for the treatment of congestive heart failure

Adult bone marrow-derived stem cells and the injured heart: just the beginning?

Contact Info

Product

Resources

About